Select Medical Holdings (SEM) Misses Q4 EPS by 14c; Offers Guidance

Select Medical Holdings (NYSE: SEM) reported Q4 EPS of $0.22, $0.14 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.58 billion.

GUIDANCE:

Select Medical Holdings sees FY2023 revenue of $6.5-6.7 billion, versus the consensus of $6.644 billion.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.

You May Also Be Interested In

• Constellation Brands (STZ) Tops Q1 EPS by 18c
• Horizon Bancorp faces $3M jury verdict in auto repossession case
• Cronos Group replaces broker for Canadian share repurchase program